Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults

The emergence of Omicron variants coincided with declining vaccine-induced protection against SARS-CoV-2. Two bivalent mRNA vaccines, mRNA-1273.222 (Moderna) and BNT162b2 Bivalent (Pfizer-BioNTech), were developed to provide greater protection against the predominate circulating variants by includin...

詳細記述

書誌詳細

主要な著者:	Hagit Kopel, Van Hung Nguyen, Catherine Boileau, Alina Bogdanov, Isabelle Winer, Thierry Ducruet, Ni Zeng, Mac Bonafede, Daina B. Esposito, David Martin, Andrew Rosen, Nicolas Van de Velde, Sten H. Vermund, Stefan Gravenstein, James A. Mansi
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2023-11-01
シリーズ:	Vaccines
主題:	mRNA-1273.222 BNT162b2 Bivalent vaccine bivalent vaccine COVID-19 vaccine hospitalization symptomatic disease
オンライン･アクセス:	https://www.mdpi.com/2076-393X/11/11/1711
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!